Serum creatinine on admission predicts long-term mortality in acute myocardial infarction patients undergoing successful primary angioplasty - Data from the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) registry

Circulation Journal

Volumn 71, Issue 9, 2007, Pages 1354-1359

  Yamaguchi, Junichi ^a   Kasanuki, Hiroshi ^a   Ishii, Yasuhiro ^a   Yagi, Masahiro ^b   Nagashima, Michitaka ^a   Fujii, Shinya ^b   Koyanagi, Ryo ^a   Ogawa, Hiroshi ^a   Hagiwara, Nobuhisa ^a   Haze, Kazuo ^c   Sumiyoshi, Tetsuya ^d   Honda, Takashi ^e  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Sendai Cardiovascular Center   (Japan)

^c OSAKA CITY GENERAL HOSPITAL   (Japan)

^d SAKAKIBARA HEART INSTITUTE   (Japan)

^e SAISEIKAI KUMAMOTO HOSPITAL   (Japan)

Author keywords

Acute myocardial infarction; Creatinine; Percutaneous coronary intervention; Prognosis

Indexed keywords

CREATININE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GROUPS BY AGE; HAZARD RATIO; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; JAPAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; REVASCULARIZATION; SEX DIFFERENCE; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS;

ACADEMIES AND INSTITUTES; ACUTE DISEASE; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CREATININE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 34548488947     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1354     Document Type: Article

References (34)

1. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13: 745-753.
2. Nakamura K, Okamura T, Hayakawa T, Kadowaki T, Kita Y, Ohnishi H, et al. Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90. Circ J 2006; 70: 954-959.
3. Herzog CA. Diagnosis and treatment of ischemic heart disease in dialysis patients. Curr Opin Nephrol Hypertens 1997; 6: 558-565.
4. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805.
5. Chertow GM, Normand SL, Silva LR, McNeil BJ. Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the cooperative cardiovascular project. Am J Kidney Dis 2000; 35: 1044-1051.
6. McCullough PA, Soman SS, Shah SS, Smith ST, Marks KR, Yee J, et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 2000; 36: 679-684.
7. Pitsavos C, Kurlaba G, Panagiotakos DB, Kogias Y, Mantas Y, Chrysohoou C, et al. Association of creatinine clearance and in-hospital mortality in patients with acute coronary syndromes: The GREECS study. Circ J 2007; 71: 9-14.
8. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M, et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001; 37: 1191-1200.
9. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, et al. Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 2002; 137: 563-570.
10. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction: The GUSTO Angiographic Investigators. N Engl J Med 1993; 329: 1615-1622.
11. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization: The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128: 194-203.
12. Hannan EL, Racz MJ, Arani DT, Ryan TJ, Walford G, McCallister BD. Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000; 36: 1194-1201.
13. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 20 2006; 296: 1377-1384.
14. Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003; 108: 2769-2775.
15. Kasanuki H, Honda T, Haze K, Sumiyoshi T, Horie T, Yagi M, et al. A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: Rationale and initial results of the HIJAMI Registry. Am Heart J 2005; 150: 411-418.
16. The Thrombolysis in Myocardial Infarction (TIMI) trial: Phase I findings. TIMI Study Group. N Engl J Med 1985; 312: 932-936.
17. Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 2003; 42: 1535-1543.
18. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
19. Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM. Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 2003; 63: 696-701.
20. Pinkau T, Mann JF, Ndrepepa G, Mehilli J, Hadamitzky M, Braun S, et al. Coronary revascularization in patients with renal insufficiency: Restenosis rate and cardiovascular outcomes. Am J Kidney Dis 2004; 44: 627-635.
21. Becker BN, Himmelfarb J, Henrich WL, Hakim RM. Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 1997; 8: 475-486.
22. Fleck C, Schweitzer F, Karge E, Busch M, Stein G. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clin Chim Acta 2003; 336: 1-12.
23. Cauza E, Kletzmaier J, Bodlaj G, Dunky A, Herrmann W, Kostner K. Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function. Nephrol Dial Transplant 2003; 18: 1568-1572.
24. Dohi Y, Ohashi M, Sugiyama M, Takase H, Sato K, Ueda R. Circulating thrombomodulin levels are related to latent progression of atherosclerosis in hypertensive patients. Hypertens Res 2003; 26: 479-483.
25. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
26. Sorensen CR, Brendorp B, Rask-Madsen C, Kober L, Kjoller E, Torp-Pedersen C. The prognostic importance of creatinine clearance after acute myocardial infarction. Eur Heart J 2002; 23: 948-952.
27. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000; 36: 29-34.
28. Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L. Cystatin C: A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004; 110: 2342-2348.
29. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060.
30. Yamaguchi J, Kasanuki H, Ishii Y, Yagi M, Ogawa H, Fujii SY, et al. Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Cardiol 2004; 93: 1526-1528.
31. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264.
32. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542-1548.
33. Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780-1785.
34. Jujo K, Yamaguchi J, Obayashi K, Suzuki K, Sekiguchi H, Nagashima M, et al. Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography. J Cardiol 2006; 48: 9-16.